Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy

被引:10
|
作者
Mella, Alberto [1 ]
Deambrosis, Ilaria [2 ]
Mingozzi, Silvia [1 ]
Colla, Loredana [1 ]
Burdese, Manuel [1 ]
Giaretta, Fulvia [2 ]
Bruno, Stefania [2 ,3 ]
Camussi, Giovanni [3 ]
Boaglio, Elena [1 ]
Dolla, Caterina [1 ]
Clari, Roberta [1 ]
Biancone, Luigi [1 ]
机构
[1] Univ Turin, Div Nephrol Dialysis & Transplantat, Dept Med Sci, Citta Salute & Sci Hosp, I-8810126 Corso, Italy
[2] Citta Salute & Sci Hosp, Lab Nephrol & Immunopathol, Turin, Italy
[3] Univ Turin, Dept Med Sci, Turin, Italy
关键词
DISEASE-ACTIVITY; RECEPTOR; AUTOANTIBODIES; PROGRESSION; CELLS;
D O I
10.1038/s41598-020-73335-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Idiopathic membranous nephropathy (iMN) is considered an immune-mediated disease where circulating autoantibodies against podocyte targets (mainly the PLA(2)R) cause the deposition of in-situ subepithelial immune-complexes. The consequent podocyte damage may cause cell detachment in urine (Podocyturia-PdoU). PdoU has been assessed in different kidney diseases, but limited data are available in iMN. In this study all patients with a diagnosis of iMN between 15/12/1999-16/07/2014 were tested for PLA(2)R antibodies (Ab anti-PLA(2)R, ELISA kit) and PdoU by flow cytometry with anti-podocalyxin antibody. A semi-quantitative PdoU score was defined according to the percentage of podocalyxin positive cells normalized to the total volume of sample and set relative to the urine creatinine measured in the supernatant. PdoU was positive in 17/27 patients (63%; 1+score in 6/27-22.2%, 2+in 4/27-14.8%, 3+in 2/27-7.4%, 4+in 5/27-18.5%). Only 2/7 patients with complete remission showed a positive PdoU (1+) while all six patients without remission have significant PdoU. PdoU+was statistically correlated with the absence of remission and Ab anti-PLA(2)R+(p<0.05) but PdoU, analysed as a continuous variable, showed a non-linear correlation with proteinuria or PLA(2)R antibody levels also in the cohort of patients with two available PdoU tests. In conclusion, PdoU could be detected in iMN and seems to be associated with commonly considered markers of disease activity (proteinuria and Ab anti-PLA(2)R) with a non-linear correlation. Despite data should be confirmed in large and prospective cohorts, according to the podocyte depletion hypothesis PdoU may represent an early marker of immunological activation with potential prognostic utility.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Observation of the efficacy and safety of obinutuzumab in the treatment of refractory idiopathic membranous nephropathy
    Li, Luyao
    Wang, Sha
    Wei, Mingming
    Zhang, Qi
    Fang, Lin
    Fan, Xin
    Cheng, Miaomiao
    Zhang, Chengrui
    Liang, Hua
    Xiao, Xiaoyan
    Yang, Xiangdong
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2025,
  • [32] Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort
    Wang, Xin
    Cui, Zhao
    Zhang, Yi-Miao
    Qu, Zhen
    Wan, Fang
    Meng, Li-Qiang
    Cheng, Xu-Yang
    Liu, Gang
    Zhou, Fu-de
    Zhao, Ming-Hui
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (09) : 1558 - 1563
  • [33] A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)
    Fervenza, Fernando C.
    Canetta, Pietro A.
    Barbour, Sean J.
    Lafayette, Richard A.
    Rovin, Brad H.
    Aslam, Nabeel
    Hladunewich, Michelle A.
    Irazabal, Maria V.
    Sethi, Sanjeev
    Gipson, Debbie S.
    Reich, Heather N.
    Brenchley, Paul
    Kretzler, Matthias
    Radhakrishnan, Jai
    Hebert, Lee A.
    Gipson, Patrick E.
    Thomas, Leslie F.
    McCarthy, Ellen T.
    Appel, Gerald B.
    Jefferson, J. Ashley
    Eirin, Alfonso
    Lieske, John C.
    Hogan, Marie C.
    Greene, Eddie L.
    Dillon, John J.
    Leung, Nelson
    Sedor, John R.
    Rizk, Dana V.
    Blumenthal, Samuel S.
    Lasic, Lada B.
    Juncos, Luis A.
    Green, Dollie F.
    Simon, James
    Sussman, Amy N.
    Philibert, David
    Cattran, Daniel C.
    NEPHRON, 2015, 130 (03) : 159 - 168
  • [34] Clinicopathological and prognostic characteristics of idiopathic membranous nephropathy with dual antigen positivity
    Yang, Lei
    Wang, Guoqin
    Ye, Nan
    Xu, Xiaoyi
    Cheng, Wenrong
    Sun, Lijun
    Dong, Hongrui
    Kong, Lingqiang
    Zhao, Xiaoyi
    Geng, Yanqiu
    Cheng, Hong
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [35] Circulating TNF Receptors Are Significant Prognostic Biomarkers for Idiopathic Membranous Nephropathy
    Lee, Su Mi
    Yang, SeungHee
    Cha, Ran-Hui
    Kim, Myounghee
    An, Jung Nam
    Paik, Jin Ho
    Kim, Dong Ki
    Kang, Shin-Wook
    Lim, Chun Soo
    Kim, Yon Su
    Lee, Jung Pyo
    PLOS ONE, 2014, 9 (08):
  • [36] Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
    Tomas, Nicola M.
    Beck, Laurence H., Jr.
    Meyer-Schwesinger, Catherine
    Seitz-Polski, Barbara
    Ma, Hong
    Zahner, Gunther
    Dolla, Guillaume
    Hoxha, Elion
    Helmchen, Udo
    Dabert-Gay, Anne-Sophie
    Debayle, Delphine
    Merchant, Michael
    Klein, Jon
    Salant, David J.
    Stahl, Rolf A. K.
    Lambeau, Gerard
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (24): : 2277 - 2287
  • [37] Long-term outcomes of initial therapy for idiopathic membranous nephropathy
    Sato, Masayo
    Takei, Takashi
    Moriyama, Takahito
    Itabashi, Mitsuyo
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (05) : 842 - 851
  • [38] Annexin A1 may contribute to the morphological changes in podocytes by mediating endocytic vesicle fusion and transport via promotion of SNARE assembly in idiopathic membranous nephropathy
    Song, Lei
    Shen, Wen
    Wang, Le
    Song, Jianling
    Tu, Weiping
    Ke, Ben
    Fang, Xiangdong
    NEPHROLOGY, 2024, 29 (02) : 76 - 85
  • [39] Diagnostic utility of serum and urine biomarkers in idiopathic membranous nephropathy: a systematic review and meta-analysis
    Gao, Dan
    Lu, Li-Ping
    Zhao, Zhi-Guo
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (10) : 2517 - 2526
  • [40] Level of interleukin-35 in patients with idiopathic membranous nephropathy and its predictive value for remission time
    Zhang, Na
    Dai, Haoran
    Dong, Xuan
    Liu, Wenbin
    Jiang, Hanxue
    Zhao, Qihan
    Gao, Yu
    Feng, Zhendong
    Dong, Zhaocheng
    Hu, Yuehong
    Huang, Guangrui
    Rui, Hongliang
    Liu, Baoli
    FRONTIERS IN IMMUNOLOGY, 2022, 13